nexsi valu proposit clear continu see
larg contract contribut interim margin
inflect de-risk financi stori provid glimps
futur nexsi penetr could mean
top bottom line beat haemonet report revenu
organ slightli better estim plasma organ
growth rel line driven favor price volum mix
continu penetr nexsi blood center revenu
organ estim driven declin transfus
rate whole blood slightli off-set hospit revenu
organ miss estim cell salvag
manag growth weaker expect gross margin
pt estim margin bp
estim mainli driven gross margin drop-through discuss
slightli off-set higher sg expens ep beat estim
preview like mainli driven margin vs
mse tax vs mse
gross margin look sustain gross margin bp y/i beat
estim bp driven price benefit improv mix lower margin
facil divestitur benefit complex reduct program gm
drop-through drove oper margin upsid bp vs mse
margin guidanc rais pt midpoint
updat margin guidanc impli ep consist
bottom line rais y/i beat
vs model one-tim softwar contract drive pt gm
expans underli trend look sustain consid continu price
tailwind divestitur union complex reduct
program gross margin like reach new baselin reflect
chang model impli gross margin ebit margin
ep near top end guidanc thesi perspect
signific margin upsid illustr multipl driver outsiz
ep growth provid glimps contribut larg plasma
medic technolog unit state america
unless otherwis note metric base modelwar
consensu data provid thomson reuter estim
seek busi
compani cover morgan stanley research
result investor awar firm may
conflict interest could affect object
morgan stanley research investor consid
morgan stanley research singl factor make
invest decis
analyst certif import disclosur
refer disclosur section locat end
nexsi thesi intact analysi suggest nexsi system placement
increas modestli sequenti collect reach date
impli extra liter plasma least increment
center revenu assum cost per liter commentari around increas
yield cost consist dilig upgrad thesi increas
confid larg contract win matter inventori
continu ramp second straight quarter q/q growth
larg reflect nexsi build manag chang posit
regard build inventori ahead contract sign although would like
maintain flexibl posit deliv ampl system opportun
aris expect learn anyth increment regard new
custom contract call dilig exist center util
nexsi system remain favor continu model larg custom
contract contribut
growth outlook rel unchang follow organ growth
beat estim pt maintain organ growth
guidanc segment guidanc unchang model rel
unchang top-line organ growth plasma model
organ growth top end segment guidanc remain comfort
estim assum north american end-market low teen increment
nexsi placement guidanc organ growth hospit segment
impli pt momentum acceler order reach low end
guidanc evid momentum quarter comp
hemostasi eas meaning second half comfort
low end
deliv growth earn remain overweight guidanc lrp
commentari provid may see larg view de-risk event
catalyz stock movement may june sinc last
earn releas strong perform gate
compani move de-risk lrp target without presenc new larg
custom contract could sign later year nexsi remain core
driver thesi howev discuss opportun beyond nexsi
includ teg oper leverag restructur program balanc sheet
deploy via share buyback compani continu
execut oper initi improv margin continu see
path exceed compani lrp model ebit
target updat price target base
ebitda estim premium smid cap compar given slightli
higher organ growth profil meaning greater margin earn
haemonet nexsi drive transform stori
haemonet nexsi drive transform stori
price target reflect ebitda premium
upsid nexsi price complex reduct initi dropthrough
balanc sheet option drive ebit achiev
per liter increment plasma price nexsi greater cost
save drop balanc sheet option third parti financ
capit deploy drive materi upsid ebit
nexsi complex reduct initi drive ebit
haemonet abl achiev favor increment plasma price
nexsi save help compani exceed lrp ebit object
nexsi unabl gain materi price benefit nexsi unabl
creat materi valu custom and/or unabl obtain
competit price plasma growth remain line market growth rate
minim cost save drop
stori tie long-
rang plan lrp doubl oper incom
quadrupl turnaround
primarili lever nexsi product
compani next-gener plasma
valu creation materi yield
opportun appreci see
posit backdrop nexsi drive
valu per liter plasma
custom expect share
profit increment per
liter price indic nexsi alon
drive lrp object
complex reduct initi
seek provid cost save
add option de-risk
lrp believ allow haemonet
exceed lrp object
nexsi valu price potenti
drop-through
risk achiev price
benefit nexsi ii identif
addit cost opportun iii capit
downsid risk includ nexsi
disappoint ii cost save fail materi
iii blood bank slow materi iv
million except ep
sale
sale
sale
sale
sale
sale
good sold
equival
accum comprehens incom
loss asset dispos
chang work capit
net provid oper activ
capit intang asset
sale properti invest
net use invest activ
chang equiti
net financ activ
net chang
equival bop
equival eop
